Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Expert Review of Anticancer Therapy
|
April 1, 2017
Tackling non-muscle invasive bladder cancer in the clinic
Solomon L Woldu, Öner Şanli, Yair Lotan
BJU International
|
January 7, 2017
Guideline of guidelines: non-muscle-invasive bladder cancer
Solomon L Woldu, Aditya Bagrodia, Yair Lotan
Urology Practice
|
May 5, 2023
Editorial Commentary
Solomon L Woldu, Xiaosong Meng, Aditya Bagrodia
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 29, 2020
Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era
Jeffrey M Howard, Vitaly Margulis, Solomon L Woldu
Current Opinion in Urology
|
September 2, 2016
Testicular germ cell tumor genomics
Solomon L Woldu, James F Amatruda, Aditya Bagrodia
Current Urology Reports
|
January 13, 2016
Renal Function Following Nephron Sparing Procedures: Simply a Matter of Volume?
Michael J Biles, G Joel DeCastro, Solomon L Woldu
Urology Case Reports
|
May 23, 2018
What is the role of nephrectomy following complete response to checkpoint inhibitors?
Solomon L Woldu, James Brugarolas, Payal Kapur, et al.
Expert Opinion on Pharmacotherapy
|
May 9, 2017
Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer
Timothy N Clinton, Solomon L Woldu, Ganesh V Raj
Cancer
|
October 7, 2018
Validating the predictors of outcomes after radical cystectomy for bladder cancer
Solomon L Woldu, Oner Sanli, Timothy N Clinton, et al.
JAMA Network Open
|
June 9, 2021
Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States
Jeffrey M Howard, Karabi Nandy, Solomon L Woldu, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Expert Review of Anticancer Therapy
|
April 1, 2017
Tackling non-muscle invasive bladder cancer in the clinic
Solomon L Woldu, Öner Şanli, Yair Lotan
BJU International
|
January 7, 2017
Guideline of guidelines: non-muscle-invasive bladder cancer
Solomon L Woldu, Aditya Bagrodia, Yair Lotan
Urology Practice
|
May 5, 2023
Editorial Commentary
Solomon L Woldu, Xiaosong Meng, Aditya Bagrodia
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 29, 2020
Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era
Jeffrey M Howard, Vitaly Margulis, Solomon L Woldu
Current Opinion in Urology
|
September 2, 2016
Testicular germ cell tumor genomics
Solomon L Woldu, James F Amatruda, Aditya Bagrodia
Current Urology Reports
|
January 13, 2016
Renal Function Following Nephron Sparing Procedures: Simply a Matter of Volume?
Michael J Biles, G Joel DeCastro, Solomon L Woldu
Urology Case Reports
|
May 23, 2018
What is the role of nephrectomy following complete response to checkpoint inhibitors?
Solomon L Woldu, James Brugarolas, Payal Kapur, et al.
Expert Opinion on Pharmacotherapy
|
May 9, 2017
Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer
Timothy N Clinton, Solomon L Woldu, Ganesh V Raj
Cancer
|
October 7, 2018
Validating the predictors of outcomes after radical cystectomy for bladder cancer
Solomon L Woldu, Oner Sanli, Timothy N Clinton, et al.
JAMA Network Open
|
June 9, 2021
Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States
Jeffrey M Howard, Karabi Nandy, Solomon L Woldu, et al.
Page
of 12